Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5IZF

Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1408

Summary for 5IZF
Entry DOI10.2210/pdb5izf/pdb
DescriptorcAMP-dependent protein kinase catalytic subunit alpha, 6J9-ZEU-DAR-ACA-DAR-NH2, SULFATE ION, ... (4 entities in total)
Functional Keywordsprotein kinase, inhibitor, bisubstrate, oligoarginine, pka, transferase
Biological sourceHomo sapiens (Human)
More
Cellular locationCytoplasm. Isoform 2: Cell projection, cilium, flagellum: P17612
Total number of polymer chains2
Total formula weight41991.82
Authors
Pflug, A.,Enkvist, E.,Uri, A.,Engh, R.A. (deposition date: 2016-03-25, release date: 2016-07-20, Last modification date: 2024-11-06)
Primary citationIvan, T.,Enkvist, E.,Viira, B.,Manoharan, G.B.,Raidaru, G.,Pflug, A.,Alam, K.A.,Zaccolo, M.,Engh, R.A.,Uri, A.
Bifunctional Ligands for Inhibition of Tight-Binding Protein-Protein Interactions.
Bioconjug.Chem., 27:1900-1910, 2016
Cited by
PubMed Abstract: The acknowledged potential of small-molecule therapeutics targeting disease-related protein-protein interactions (PPIs) has promoted active research in this field. The strategy of using small molecule inhibitors (SMIs) to fight strong (tight-binding) PPIs tends to fall short due to the flat and wide interfaces of PPIs. Here we propose a biligand approach for disruption of strong PPIs. The potential of this approach was realized for disruption of the tight-binding (KD = 100 pM) tetrameric holoenzyme of cAMP-dependent protein kinase (PKA). Supported by X-ray analysis of cocrystals, bifunctional inhibitors (ARC-inhibitors) were constructed that simultaneously associated with both the ATP-pocket and the PPI interface area of the catalytic subunit of PKA (PKAc). Bifunctional inhibitor ARC-1411, possessing a KD value of 3 pM toward PKAc, induced the dissociation of the PKA holoenzyme with a low-nanomolar IC50, whereas the ATP-competitive inhibitor H89 bound to the PKA holoenzyme without disruption of the protein tetramer.
PubMed: 27389935
DOI: 10.1021/acs.bioconjchem.6b00293
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

235183

PDB entries from 2025-04-23

PDB statisticsPDBj update infoContact PDBjnumon